Business
Appointment of Nominated Adviser and Broker
Appointment of Nominated Adviser and Broker.
About this update from Rua Life Sciences Plc
[{"type":"text","content":"\n \n \n 19 May 2022\n \n \n \n \n \n \n RUA Life Sciences Plc\n \n \n \n \n \n \n \n \n \n (\"RUA Life Sciences\", the \"Company\" or the \"Group\")\n \n \n \n \n Appointment of Nominated Adviser and Sole Broker\n \n \n \n RUA Life Sciences, the holding company of a group of medical device businesses focused on the exploitation of the patented long-term implantable biostable polymer, announces it has appointed Cenkos Securities plc as the Company's nominated adviser and sole broker with immediate effect.\n \n \n \n \n \n Cenkos Securities plc has been the Company's joint broker since December 2020.\n \n \n \n \n \n \n \n \n \n For further information contact:\n \n \n \n \n \n \n \n RUA Life Sciences plc\n \n \n \n Bill Brown, Chairman Tel: +44 (0) 77 3071 8296\n \n \n Caroline Stretton, Group Managing Director Tel: +44 (0) 7789 901269\n \n \n \n \n \n \n Cenkos Securities plc\n \n (Nominated Adviser and Broker) \n Tel: +44 (0) 20 7397 8900\n \n \n Giles Balleny/Max Gould (Corporate Finance)\n \n \n Michael Johnson (Sales)\n \n \n \n \n \n \n \n \n \n About RUA Life Sciences\n \n \n \n The RUA Life Sciences group was created in April 2020 when RUA Life Sciences Plc (formerly known as AorTech International Plc) acquired RUA Medical Devices Limited to create a fully formed medical device business. RUA Life Sciences is the holding company of the Group's four trading businesses, each exploiting the Group's patented polymer technology.\n \n \n Our vision is to improve the lives of millions of patients by improving and enabling medical devices with Elast-EonTM, the world's leading long-term implantable polyurethane.\n \n \n Whether it is licensing Elast-EonTM, manufacturing a device or component or ...